Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Celularity (CELU) reported Return on Capital Employed [ROCE] of -129.52% for Q2 2026, down 44.33 percentage points from -85.19% a year earlier but up 56.20 percentage points from the prior quarter.

Analysis

Celularity (CELU) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Celularity posted Return on Capital Employed [ROCE] of -156.21%, down 110.88 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -110.81 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -45.34% in FY2024 (+48.38 pp), -93.72% in FY2023 (-86.31 pp), -7.41% in FY2022 (+20.11 pp) and -27.52% in FY2021 (+17.88 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -231.00% in Q4 2023 and a high of -7.17% in Q4 2022.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last four quarters, with an average year-over-year change of +12.18 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2024 (a gain of 181.23 percentage points); the low point was Q4 2023 (a drop of 223.83 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -185.72% (Q1 2026), -204.19% (Q4 2025) and -93.42% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,141.09 Bn 1,109.67 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.15 Bn 555.01 Bn 17.30 Bn 17.52%
3 AbbVie 501.95 Bn 475.07 Bn 12.70 Bn 17.92%
4 Merck 356.40 Bn 310.78 Bn 12.21 Bn 6.28%
5 Novartis Ag 300.55 Bn 264.54 Bn 11.24 Bn 19.32%
6 Astrazeneca 263.27 Bn 236.95 Bn 12.86 Bn 16.76%
7 Amgen 237.82 Bn 193.22 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.11 Bn 168.30 Bn 6.22 Bn -5.97%
9 Pfizer 170.27 Bn 116.91 Bn 10.94 Bn 11.86%
10 Celularity 27.75 Mn 20.50 Mn 3.09 Mn -129.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -129.52%
Mar 31, 2026 -185.72%
Dec 31, 2025 -204.19%
Sep 30, 2025 -93.42%
Jun 30, 2025 -85.19%
Mar 31, 2025 -57.52%
Dec 31, 2024 -49.76%
Sep 30, 2024 -28.15%
Jun 30, 2024 -144.23%
Mar 31, 2024 -174.52%
Dec 31, 2023 -231.00%
Sep 30, 2023 -160.55%
Jun 30, 2023 -39.47%
Mar 31, 2023 -15.18%
Dec 31, 2022 -7.17%
Sep 30, 2022 -15.94%
Jun 30, 2022 -10.40%
Mar 31, 2022 -26.69%
Dec 31, 2021 -26.93%
Sep 30, 2021 -32.05%
API Access

Celularity Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CELU&period=max&api_key=YOUR_API_KEY